Literature DB >> 31799659

MiR-187 influences cisplatin-resistance of gastric cancer cells through regulating the TGF-β/Smad signaling pathway.

Q-L Zhu1, Z Li, C-M Lv, W Wang.   

Abstract

OBJECTIVE: To explore the effect of micro-ribonucleic acid (miR)-187 on cisplatin (DDP) resistance of gastric cancer cells by regulating the transforming growth factor-β (TGF-β)/Smad signaling pathway.
MATERIALS AND METHODS: DDP-sensitivities in GES-1, SGC7901, and SGC7901/DDP cells were detected via Cell Counting Kit-8 (CCK-8) assay. The differential expression of miR-187 of these cell lines was detected by Reverse Transcription-quantitative Polymerase Chain Reaction (RT-qPCR). DDP-resistant gastric cancer cells SGC7901/DDP were divided into control group (blank control), miR-187 inhibitor group (SGC7901/DDP cells transfected with miR-187 inhibitor), and miR-187 mimic group (SGC7901/DDP cells transfected with miR-187 mimic). The protein expressions of miR-187, TGF-β1, p-Smad4, excision repair cross-complementation group 3 (ERCC3), and ERCC4 were determined through RT-qPCR, immunohistochemistry, and Western blotting. The apoptosis in each group was detected by flow cytometry.
RESULTS: MiR-187 level had a negative correlation with DDP-resistance of GES-1, SGC7901, and SGC7901/DDP cells, and among them, the GES-1 cells had the lowest DDP-resistance and the highest expression of miR-187. CCK-8 assay revealed that compared with that in the control group, DDP-resistance significantly declined in the miR-187 mimic group, while it was significantly enhanced in miR-187 inhibitor group (p<0.01). According to the results of flow cytometry, after treatment with 100 nM DDP for 12 h, the apoptotic rate in miR-187 mimic group enhanced, while it was markedly reduced in the miR-187 inhibitor group (p<0.01). Western blotting and immunohistochemistry results showed that expressions of TGF-β1 and p-Smad4 were significantly downregulated in the miR-187 mimic group, while they were upregulated in the miR-187 inhibitor group (p<0.01). Besides, compared with the control group, ERCC3 and ERCC4 were downregulated in the miR-187 mimic group, while upregulated in miR-187 inhibitor group (p<0.01).
CONCLUSIONS: The overexpression of miR-187 alleviates DDP-resistance in gastric cancer cells by inhibiting the TGF-β/Smad signaling pathway.

Entities:  

Year:  2019        PMID: 31799659     DOI: 10.26355/eurrev_201911_19556

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

Review 1.  Molecular mechanisms associated with chemoresistance in esophageal cancer.

Authors:  Matheus Lohan-Codeço; Maria Luísa Barambo-Wagner; Luiz Eurico Nasciutti; Luis Felipe Ribeiro Pinto; Nathalia Meireles Da Costa; Antonio Palumbo
Journal:  Cell Mol Life Sci       Date:  2022-02-03       Impact factor: 9.261

2.  CircRNA DONSON contributes to cisplatin resistance in gastric cancer cells by regulating miR-802/BMI1 axis.

Authors:  Yong Liu; Jianzhong Xu; Min Jiang; Lingna Ni; Yang Ling
Journal:  Cancer Cell Int       Date:  2020-06-22       Impact factor: 5.722

3.  Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis.

Authors:  Peng Deng; Ming Sun; Wen-Yan Zhao; Bin Hou; Kai Li; Tao Zhang; Feng Gu
Journal:  World J Gastroenterol       Date:  2021-02-14       Impact factor: 5.742

Review 4.  The Molecular Roles and Clinical Implications of Non-Coding RNAs in Gastric Cancer.

Authors:  Yanping Yue; Xinrong Lin; Xinyue Qiu; Lei Yang; Rui Wang
Journal:  Front Cell Dev Biol       Date:  2021-12-13

Review 5.  Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer.

Authors:  Ying Liu; Xiang Ao; Guoqiang Ji; Yuan Zhang; Wanpeng Yu; Jianxun Wang
Journal:  Front Oncol       Date:  2021-11-29       Impact factor: 6.244

Review 6.  TGF-β Signaling and Resistance to Cancer Therapy.

Authors:  Maoduo Zhang; Ying Yi Zhang; Yongze Chen; Jia Wang; Qiang Wang; Hezhe Lu
Journal:  Front Cell Dev Biol       Date:  2021-11-30

Review 7.  Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review.

Authors:  Pía Loren; Nicolás Saavedra; Kathleen Saavedra; Nadine De Godoy Torso; Marília Berlofa Visacri; Patricia Moriel; Luis A Salazar
Journal:  Front Pharmacol       Date:  2022-04-04       Impact factor: 5.988

8.  miR-187/PDLIM1 Gets Involved in Gastric Cancer Progression and Cisplatin Sensitivity of Cisplatin by Mediating the Hippo-YAP Signaling Pathway.

Authors:  Yeru Tan; Yuehua Li; Hongbo Zhu; Xiaoping Wu; Kai Mei; Pian Li; Qiao Yang
Journal:  J Oncol       Date:  2022-09-17       Impact factor: 4.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.